Published online Mar 7, 2024. doi: 10.3748/wjg.v30.i9.1164
Peer-review started: October 22, 2023
First decision: January 5, 2024
Revised: January 15, 2024
Accepted: February 7, 2024
Article in press: February 7, 2024
Published online: March 7, 2024
Processing time: 135 Days and 14.9 Hours
Liver fibrosis is a public health problem and closely associated with various prevalent causes of chronic liver damage. Early diagnosis and accurate staging of liver fibrosis are important in clinical practice. Non-invasive methods have been evaluated for diagnosing and staging liver fibrosis and have become the focus of clinical research. Diffusion-weighted imaging (DWI) represents the most widely used functional magnetic resonance imaging (MRI) sequence. Several DWI models are used in clinical practice. The quantitative information gathered from some of these models was used to detect and stage liver fibrosis.
Early liver fibrosis detection and staging are based on conventional DWI or early non-Gaussian diffusion models. The liver fibrosis staging performance and the ability to distinguish significant fibrosis (SF) of some novel DWI models were not fully clear.
In this prospective study, we investigated the value of the newest diffusion models in staging liver fibrosis and compare their performances in distinguishing SF.
This study enrolled 59 patients suspected of liver disease and scheduled for liver biopsy and 17 healthy participants without serious health problems from July 2021 to June 2022. All participants underwent multi-b value DWI and then calculated to various DWI models using an in-house software prototype developed by MR Station. The main DWI-derived parameters included Mono-apparent diffusion coefficient (ADC) from mono-exponential DWI, intravoxel incoherent motion model-derived true diffusion coefficient (IVIM-D), diffusion kurtosis imaging-derived apparent diffusivity, stretched exponential model-derived distributed diffusion coefficient (SEM-DDC), fractional order calculus (FROC) model-derived diffusion coefficient (FROC-D) and FROC model-derived microstructural quantity (FROC-μ), continuous-time random-walk (CTRW) model-derived anomalous diffusion coefficient (CTRW-D) and CTRW model-derived temporal diffusion heterogeneity index (CTRW-α). The correlations between DWI-derived parameters and fibrosis stages and the parameters’ diagnostic efficacy in detecting SF were assessed and compared.
In the current study, it was found that liver fibrosis stages differed significantly in Mono-ADC, IVIM-D, FROC-D, and CTRW-D. The fibrosis stages showed significant inverse correlations with Mono-ADC, IVIM-D, DKI-derived apparent diffusivity, SEM-DDC, FROC-D, FROC-μ, CTRW-D, and CTRW-α. The combined CTRW-derived parameters resulted in the highest areas under the ROC curve (0.747).
The CTRW-DWI model demonstrated the clinical potential in liver fibrosis staging. The combined diffusion parameters based on the various models were superior to each individual parameter in distinguishing SF.
As advanced DWI models, FROC and CTRW demonstrated their clinical potential in early detection of liver fibrosis. More patients and stratification of causes will help to generate more accurate results. Also, normalization of the DWI parameters will improve the effectiveness and power in future research.